The U.S. Food and Drug Administration (FDA) on Tuesday cleared PRF Technologies Ltd.'s PRFX Investigational New Drug application for OcuRing-K, enabling the company to move into a Phase 2 trial ...
About 90% of patients see better after surgery, says a top eye expert. Here's what experts say about the best timing for cataract surgery in both eyes.